4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001324863-26-000002
Director sold 2,000 shares at an average $539.17 ($1,078,332)
- Director acquired 2,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thompson Tommy G Director | 2026-03-26 | Option exercise | +2,000 | $101.80 | $203,600 | 10,480 | D: show line 1 in the form |
| Thompson Tommy G Director | 2026-03-26 | Sale | −275 | $537.62 | $147,845 | 10,205 | D: show line 2 in the form |
| Thompson Tommy G Director | 2026-03-26 | Sale | −1,414 | $539.25 | $762,493 | 8,791 | D: show line 3 in the form |
| Thompson Tommy G Director | 2026-03-26 | Sale | −311 | $540.18 | $167,994 | 8,480 | D: show line 4 in the form |
| Open-market sales · 2,000 sh · avg $539.17 · $1,078,332 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Thompson Tommy G Director | 2026-03-26 | Option exercise · Stock Option | −2,000 | 0 | D: show line 5 in the form |
Loading xslF345X06/primarydocument.xml…